Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 3, 2026
- Accession no.
- 0001354228-26-000005
- Filed
- Sep 3, 2026, 6:19 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $32.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | SSaleDisposed | −3,807 | $2.26 | −$8,603.82 | 372,354 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −2,224 | $2.26 | −$5,026.24 | 370,130 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −3,476 | $2.26 | −$7,855.76 | 366,654 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −4,827 | $2.26 | −$10,909.02 | 361,827 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.